The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 261-264 , March 2010

Body mass, chronic heart failure, surgery and survival

  • Andrew L. Clark, MA, MD

      Affiliations

    • Department of Academic Cardiology, Castle Hill Hospital, Hull, UK
    • Corresponding Author InformationReprint requests: Andrew Clark, MD, Department of Academic Cardiology, Castle Hill Hospital, Castle Road, Cottingham, Hull 16 5JQ, UK. Telephone: +44-1482-461775
    • ,
  • Stefan D. Anker, MD, PhD

      Affiliations

    • Charité, Campus Virchow-Klinikum, Berlin, Germany

References 

  1. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808
  2. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  3. Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29–35
  4. Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  5. Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29–35
  6. Horwich TB, Hamilton MA, Maclellan WR, et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8:216–224
  7. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077–1083
  8. Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation. 2007;116:627–636
  9. Rossner S, Taylor CL, Byington RP, et al. Long term propranolol treatment and changes in body weight after myocardial infarction. BMJ. 1990;300:902–903
  10. Riley M, Elborn JS, McKane WR, et al. Resting energy expenditure in chronic cardiac failure. Clin Sci (Lond). 1991;80:633–639
  11. Poehlman ET, Scheffers J, Gottlieb SS, et al. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994;121:860–862
  12. Witte KK, Ford SJ, Preston T, et al. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Int J Cardiol. 2008;129:363–367
  13. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  14. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526–534
  15. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521–532
  16. Torti FM, Dieckman B, Beutler BA, et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science. 1985;229:867–869
  17. Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;107:3133–3140
  18. Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;109:1594–1602
  19. Hyltander A, Daneryd P, Sandstrom R, et al. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. Eur J Cancer. 2000;36:330–334
  20. Drott C, Persson H, Lundholm K. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with or without cancer. Clin Physiol. 1989;9:427–439
  21. Bessey PQ, Watters JM, Aoki TT, et al. Combined hormonal infusion simulates the metabolic response to injury. Ann Surg. 1984;200:264–281
  22. Watters JM, Bessey PQ, Dinarello CA, et al. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg. 1986;121:179–190
  23. Hryniewicz K, Androne AS, Hudraihed A, et al. Partial reversal of cachexia by β-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Failure. 2003;9:464–468
  24. Podbregar M, Voga G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Card Fail. 2002;8:369–378
  25. Tan LB, Bruniston JG, Clark WA, et al. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: towards a new bioassay for beta-blockers. J Cardiovasc Pharmacol. 2003;41:518–525
  26. Burniston JG, Ng Y, Clark WA, et al. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol. 2002;93:1824–1832
  27. Ng Y, Goldspink DF, Burniston JG, et al. Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol. 2002;86:299–309
  28. Donahoo WT, Jensen DR, Yost TJ, et al. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab. 1997;82:4139–4143
  29. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980;65:717–721
  30. Severn A, Rapson NT, Hunter CA, et al. Regulation of tumour necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol. 1992;148:3441–3445
  31. Herndon DN, Hart DW, Wolf SE, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223–1229
  32. Abel RM, Fischer JE, Buckley MJ, et al. Malnutrition in cardiac surgical patients: results of a prospective, randomized evaluation of early postoperative parenteral nutrition. Arch Surg. 1976;111:45–50
  33. Rich MW, Keller AJ, Schechtman KB, et al. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol. 1989;63:714–718
  34. Rady MY, Ryan T, Starr NJ. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. J Parenter Enteral Nutr. 1997;21:81–90
  35. Carrier M, Rivard M, Latter D, et al. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. Can J Cardiol. 1998;14:703–707
  36. Lietz K, John R, Burke EA, et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation. 2001;72:277–283
  37. Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality? (A multi-institutional study of preoperative weight-height indices). J Heart Lung Transplant. 1999;18:750–763
  38. Clark AL, Knosalla C, Birks E, et al. Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. Eur J Heart Fail. 2007;9:839–844
  39. National Center for Health Statistics. Weight by height and age for adults 18–74 years: United States 1971–1974 (Vital and health statistics). Washington, DC: Government Printing Office; 1979;Series 11. No. 208. DHEW Publication PHS 79-1656
  40. Mano A, Fujita K, Uenomachi K, et al. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant. 2009;28:428–433
  41. Clark AL, Loebe M, Potapov EV, et al. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J. 2001;22:2275–2283

PII: S1053-2498(09)00539-7

doi: 10.1016/j.healun.2009.07.004

The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 261-264 , March 2010

Article Tools

* Image Usage & Resolution